Screener
Tectonic Therapeutics TECX Stock-Based Comp
Stock-Based Comp at other companies
Other financials
Where this comes from
Reported directly by Tectonic Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:ShareBasedCompensation.
The source filing: Tectonic Therapeutics’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 4:19 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-212016
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Net loss | $(25,241) | $(15,906) |
| Adjustments to reconcile net loss to net cash used in operating activities: | ||
| Depreciation and amortization expense | 304 | 360 |
| Stock-based compensation expense | 3,205 | 2,103 |
| Loss on disposal of property and equipment | 23 | — |
| Reduction in the carrying amount of the operating right-of-use assets | 496 | 511 |
| Change in operating assets and liabilities: | ||
| Prepaid expenses and other current assets | (46) | 2,221 |
Item 1. Financial Statements.
FAQ
- What is Tectonic Therapeutics's stock-based comp?
- Tectonic Therapeutics (TECX) reported stock-based comp of $3.21M in Q1 2026.
- How has Tectonic Therapeutics's stock-based comp changed year-over-year?
- Tectonic Therapeutics's stock-based comp increased by 52.4% year-over-year, from $2.1M to $3.21M.
- What is the long-term trend for Tectonic Therapeutics's stock-based comp?
- Over 3 years (2021 to 2025), Tectonic Therapeutics's stock-based comp has grown at a -17.3% compound annual growth rate (CAGR), from $18.58M to $10.5M.
- What does stock-based comp mean?
- Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.
Ask your AI about Tectonic Therapeutics's stock-based comp.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude